Genotoxic therapy and resistance mechanism in gliomas
Glioma is one of the most common and lethal brain tumors. Surgical resection followed by
radiotherapy plus chemotherapy is the current standard of care for patients with glioma. The …
radiotherapy plus chemotherapy is the current standard of care for patients with glioma. The …
Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives
FY Chiu, Y Yen - Biomarker Research, 2023 - Springer
Biomarker discovery and development are popular for detecting the subtle diseases.
However, biomarkers are needed to be validated and approved, and even fewer are ever …
However, biomarkers are needed to be validated and approved, and even fewer are ever …
[PDF][PDF] Reclassification of glioblastoma multiforme according to the 2021 World Health Organization classification of central nervous system tumors: a single institution …
The 2021 World Health Organization (WHO) classification of tumors of the central nervous
system (CNS) has introduced significant changes to tumor taxonomy. One of the most …
system (CNS) has introduced significant changes to tumor taxonomy. One of the most …
[HTML][HTML] Qualitative and quantitative magnetic resonance imaging phenotypes may predict CDKN2A/B homozygous deletion status in isocitrate dehydrogenase …
Objective Cyclin-dependent kinase inhibitor (CDKN) 2A/B homozygous deletion is a key
molecular marker of isocitrate dehydrogenase (IDH)-mutant astrocytomas in the 2021 World …
molecular marker of isocitrate dehydrogenase (IDH)-mutant astrocytomas in the 2021 World …
Diffusion-tensor imaging and dynamic susceptibility contrast MRIs improve radiomics-based machine learning model of MGMT promoter methylation status in …
TNT Minh, VH Le, NQK Le - Biomedical Signal Processing and Control, 2023 - Elsevier
Background Determining the O6-methylguanine-DNA methyltransferase (MGMT) promoter
methylation status, which is a predictor of response to standard radiotherapy treatment in …
methylation status, which is a predictor of response to standard radiotherapy treatment in …
Validation of MRI-based models to predict MGMT promoter methylation in gliomas: BraTS 2021 radiogenomics challenge
Simple Summary O6-methylguanine-DNA methyl transferase (MGMT) methylation in
glioblastoma is an important prognostic and predictive factor that requires an invasive …
glioblastoma is an important prognostic and predictive factor that requires an invasive …
Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion …
Y Li, P Wang, J Zhang, J Li, L Chen… - Journal of Magnetic …, 2022 - Wiley Online Library
Background Intracranial germ cell tumors (iGCTs) are classified into two pathological
subtypes (germinomas [GEs] and nongerminomatous germ cell tumors [NGGCTs]), with …
subtypes (germinomas [GEs] and nongerminomatous germ cell tumors [NGGCTs]), with …
Hemodynamic Imaging in Cerebral Diffuse Glioma—Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions
Simple Summary Cerebral diffuse gliomas present peculiar molecular features tightly linked
to phenotypic characteristics that are not readily appreciated by means of standard …
to phenotypic characteristics that are not readily appreciated by means of standard …
[HTML][HTML] Increased ASF1B expression correlates with poor prognosis in patients with gliomas
H Zhu, H Ouyang, X Pan, Z Zhang, J Tan, N Yu… - Frontiers in …, 2022 - frontiersin.org
Background: Recent studies have shown that Anti-silencing function 1 B (ASF1B) may be a
new potential marker of tumor prognosis. But the expression and function of ASF1B in …
new potential marker of tumor prognosis. But the expression and function of ASF1B in …
Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and …
E Steidl, K Filipski, E Hattingen, JP Steinbach… - Plos one, 2023 - journals.plos.org
Introduction When evaluating MRIs for glioblastoma progression, previous scans are usually
included into the review. Nowadays dynamic susceptibility contrast (DSC)-perfusion is an …
included into the review. Nowadays dynamic susceptibility contrast (DSC)-perfusion is an …
